In addition to administrative databases, there are other more specialty focused databases that have been created by medical societies, such as the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) and the Society of Thoracic Surgeons National Database. Neurosurgery too has its own registries-the most well-known is the Quality Outcomes Database, formerly known as the National Neurosurgery Quality and Outcomes Database (N2QOD). 1 Others have been created by disease-specific research groups, such as the Park-Reeves Syringomyelia Research Consortium and the Hydrocephalus Clinic Research Network (HCRN). 2 Kondziolka et al 3 recently detailed creation of a comprehensive radiosurgery registry.
The use of such non-neurosurgery-specific big databases has become an increasingly popular form of clinical research in neurosurgery. It is common to find at least 1 such article on any given month in any of the leading neurosurgical journals. "Big data" has a number of major limitations as sources for healthcare research, such as lack of validation, inability to distinguish some healthcare outcomes from pre-existing conditions, and failure to include specific clinical data that are vital for risk adjustment (such as severity of disease), but our impression and that of others has been that the use of these data sources is increasing in frequency in neurosurgical journals. This investigation was undertaken to perform a panoramic evaluation of the ascension of such studies within the neurosurgical literature.
Studies were classified according to a broad or general topic, as well as a more specific subtopic. The broad topic was defined as the neurosurgical subspecialty relevant to the aims of each article. These categories included pediatrics, functional/epilepsy, neuro-oncology, vascular, spine, and-for those topics that did not fit into the aforementioned subspecialtiesgeneral neurosurgery. The subtopic was a more specific categorization of the study's broad topic. For example, a study may be classified with the broad topic "vascular" and the subtopic "aneurysm." If an article appeared to fit the definition of more than 1 broad topic, final category designation was achieved by discussion and consensus among the authors.
The study objective was defined as the measured criteria used to support the conclusions of each article. These were categorized as "Outcomes, " "Cost, " "Complications, " and "Other." "Outcomes" was defined as consequences (morbidity or mortality) as a result of the natural history or treatment of a neurosurgical disease. Examples of morbidity would include postoperative urinary tract infection, pneumonia, or deep vein thrombosis. Another example of an outcome would be tumor recurrence or progression after resection. "Cost" was defined as the measure of monetary expenditures or savings associated with a neurosurgical intervention or disease. "Complications" was defined as unintended consequences directly resulting from a neurosurgical intervention. Examples include cerebrospinal fluid leak or wound infection; postprocedural morbidity not directly tied to surgery would fall in the Outcomes category. "Other" was defined as a paper that did not fit into the aforementioned objectives. Examples include political, socioeconomic, or epidemiologic aspects of neurosurgical diseases or the evaluation of neurosurgical quality metrics. If an article investigated multiple objectives, the following order of descending precedence was used to establish the study objective: Cost, Outcomes, Complications, and Other.
Study Questions
We sought to answer the following questions:
1. How many papers using "big data" have been published in 3 North
American neurosurgical journals since 2000?
2. Which databases are being used? 3. What are the study topics and objectives? 4. Which institutions are authoring these papers?
RESULTS
Our initial keyword search yielded 183 articles. The manual search of the journals yielded an additional 90, and a third search to include publications available through December 2016 yielded a new total of 324 articles. Articles using administrative databases were excluded from the final listing, if they utilized "big data" from a country other than the United States. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] Two additional articles were excluded because 1 used the data to determine the procedure-related litigation risk, 24 and the other used hospitallevel administrative data rather than patient-level data. 25 The included articles were tallied and found to have been published in the following journals (listed in descending order): Journal of Neurosurgery Publishing Group (n = 200), Neurosurgery (n = 71), and World Neurosurgery (n = 53). Since 2000, the total number of published articles per year was flat until 2011 with an exponential rise since then, reaching 53 in 2015 and 78 in 2016 ( Figure 1 ). Figure 2 shows the number of articles published per year by the 3 journals. Table 2 consolidates the publication output from the 3 journals into 3 discrete time intervals, which again demonstrates the dramatic rise since 2010.
The top utilized databases were the Healthcare Cost and Utilization Project National Inpatient Sample (HCUP NIS; n = 136), ACS NSQIP (n = 39), and Surveillance, Epidemiology, and End Results (SEER; n = 35; Table 3 ). The mean sample size was 114,841 subjects per study, with a range of 30-4,146,777. Table 3 also displays the average samples sizes by specific database. Table 4 shows the broad and specific topics, with vascular (n = 77) and neuro-oncology (n = 66) being the most common. Table 5 details the study objectives broken down by study topic. The most common study objective was Outcomes (n = 154) followed by Cost (n = 65) and Other (n = 62). Publications were also examined according to the academic institution affiliation of the primary (Table 6 ) and senior (Table 7) authors. The most frequently represented institutions by primary author were Harvard Medical School (n = 31), Stanford University (n = 17), and Johns Hopkins University (n = 14). All primary authors represented 90 unique institutions, and the top 10 represented institutions accounted for 44.8% of all publications. By senior author, the most represented institutions were Harvard Medical School (n = 28), Stanford University (n = 16), and University of California San Francisco (n = 16). All senior authors represented 87 unique institutions, and the top 11 represented institutions by senior author accounted for 48.5% of all publications. When considering both primary and senior authorship, Harvard Medical School had the greatest representation with 59 in total (31 primary authors and 28 senior authors) and 35 unique publications (in 24 publications both the primary and senior authors were from Harvard Medical School).
DISCUSSION
In the past decade or more within the US healthcare system, there has been a sustained effort to intensify outcomes reporting, establish benchmarks, examine complications rates, and define socalled "never events." Concurrently, there is a growing movement to link physician and hospital reimbursement with the delivery of quality healthcare. One of the fruits of this monumental shift in healthcare philosophy has been the rise of research studies utilizing databases that contain electronic medical records on enormous numbers of patients, a trend that has most definitely found its way into neurosurgery. Though the increasing popularity of such studies within neurosurgery has been anecdotally recognized for a while, our study sought to detail the phenomenon we have dubbed "big data" research.
Our Results
What was initially a steady trickle is now a tidal wave. There has been an exponential increase in the number of "big data" articles published since 2010. Seventy-eight articles have been published (in print or online) in 2016, compared with 53 and 49 articles total in 2015 and 2014, respectively. While the Journal of Neurosurgery Publishing Group had the highest number of papers (n = 200), World Neurosurgery had approximately three-quarters as many articles as Neurosurgery (n = 53 vs n = 71) during its shorter publishing existence of approximately 6.5 years.
The rapid rise in big data research may be multifactorial. It was and still is a relatively new research platform that is steadily making appearances in our journals and meetings, and is already Note: some articles utilized more than 1 database, hence the reason why 327 databases were used in 324 papers.
finding popularity in other areas of medicine, such as general surgery. Most importantly, it is much easier (as detailed below) than traditional clinical research-many researchers saw it as an ideal and efficient way to gain access to a large amount of data. It may have also gained momentum alongside medicine's overall shift toward quality and outcomes reporting, or it may have been propelled by certain legislation. In 2006, the Physician Quality Reporting Initiative (since renamed Physician Quality Reporting System) was established by the Centers for Medicare and Medicaid Services (CMS) and provided reimbursement [122] [123] [124] [125] [126] 5 (6.5) Vascular malformation [127] [128] [129] 3 (3.9) Other 130 1 (1.3) Neuro-oncology 66 (20.4) Cranial nerve neoplasm 131, 132 2 (3.0) Craniotomy for tumor [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] 11 (16.7) Glioma [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] 16 (24.2) Hemangiopericytoma 160, 161 2 (3.0) Intracranial neoplasm, not otherwise specified 162-166 5 (7.6) Meningioma [167] [168] [169] [170] [171] [172] [173] [174] 8 (12.1) Metastatic brain/spine [175] [176] [177] [178] [179] 5 (7.6) Pituitary tumor [180] [181] [182] 3 (4.5) Spinal neoplasm [183] [184] [185] [186] [187] [188] [189] 7 (10.6) Vestibular schwannoma [190] [191] [192] 3 (4.5) Other [193] [194] [195] [196] 4 (6.1) General neurosurgery 61 (18.8) Craniotomy [197] [198] [199] [200] 4 (6.6) Hydrocephalus [201] [202] [203] [204] [205] [206] 6 (9.8) Idiopathic intracranial hypertension 207, 208 2 (3.3) Multiple subtopics 209, 210 2 (3.3) Neurosurgical procedure (any) [211] [212] [213] [214] [215] [216] 6 (9.8) Peripheral nerve injuries 217, 218 2 (3.3) Resident involvement [219] [220] [221] [222] [223] [224] [225] [226] [227] 9 (14.8) Surgical site infection 228, 229 2 (3.3) Traumatic brain injury [230] [231] [232] [233] [234] [235] [236] [237] [238] [239] [240] 11 (18.0) Transphenoidal surgery [241] [242] [243] 3 (4.9) Trauma [244] [245] [246] [247] 4 (6.6) Venous thromboembolism [248] [249] [250] [251] 4 (6.6) Other [252] [253] [254] [255] [256] [257] 6 (9.8) Pediatrics 56 (17.3) Cerebrovascular 258, 259 2 (3.6) Chiari Malformation 260, 261 2 (3.6) Craniosynostosis 262, 263 2 (3.6) Epilepsy 264, 265 2 (3.6) Head injury [266] [267] [268] [269] 4 (7.1) Hydrocephalus [270] [271] [272] [273] [274] [275] [276] [277] [278] [279] [280] [281] [282] [283] [284] 15 (26.8) Intraventricular hemorrhage 285, 286 2 (3.6) Myelomeningocele 287, 288 2 (3.6) Neoplasm [289] [290] [291] [292] [293] [294] [295] 7 (12.5) Peripheral nerve injuries 296, 297 2 (3.6) Spine [298] [299] [300] [301] [302] [303] [304] [305] [306] 9 (16.1) Traumatic brain injury [307] [308] [309] [310] [311] 5 (8. incentives for physicians who reported their quality outcomes data. 26 These incentives for reporting were eventually replaced with penalties for not reporting by the 2010 Affordable Care Act. In 2009, CMS also implemented a value-base purchasing (VBP) policy in order to tie hospital reimbursements to certain measures of quality. 27 The Medicare Access and CHIP (Children's Health Insurance Program) Reauthorization Act (MACRA), set to be implemented in the year 2017, 28 is an updated continuation of the VBP policy. These policies have led to the creation and utilization of big datasets, against which hospitals and physicians can benchmark the quality of their services. Between qualitybased reimbursement policies and outcomes reporting on a national scale, it appears that the efforts of clinical researchers have also come to focus on using this nationwide data for populationlevel analyses. It is possible that the timing of these CMS policies played a role in the substantial rise in big data studies in neurosurgery since 2010.
Two of the most popular big databases were those within the HCUP: NIS (n = 136) and the Kids' Inpatient Database (KID; n = 24). The top 5 databases-which also include NSQIP, SEER, and Medicare claims data-account for 76% (246/324) of big data articles. Because each database is created and maintained differently, each has its own set of advantages and disadvantages. A full analysis of each database is beyond the scope of this paper, but we will provide some details for the more popular ones. That they contain inpatient information is complementary to many questions relevant in clinical neurosurgery. However, the HCUP NIS, KID, and some of the Medicare claims files contain only inpatient information, and thus are inherently limited in their ability to provide outcomes following discharge. The HCUP have limited outcomes at time of discharge, such as complications, discharge disposition, death, and length of stay. They have the distinct advantage of having socioeconomic variables, such as median household income for ZIP code of residence, and insurance status (Medicaid, private insurance, self-pay, other) as well as surgeon (eg, procedure volume) and hospital-specific data (eg, location by region within the US, teaching status, and number of beds). The NIS and KID were created in such a way to produce national estimates. Of all encounters that occur in each network, the NIS estimates a 20% sample; the KID a 10% sample of newborns and an 80% sample of other pediatric discharges; the CMS National Claims History estimates a 5% sample. It is important to realize that conclusions drawn from these datasets are therefore more accurately described as "population-based estimates" of particular outcomes or survival, rather than true nationwide rates or incidences.
NSQIP, on the other hand, contains well over 100 variables per patient and up to 30 days postoperatively. Data categories include demographics, surgical profile, and preoperative, intraoperative, and postoperative data. Captured postoperative events include complications, readmissions, and reoperations. The data abstractors are ACS-trained and -certified. However, the database was created by general surgeons and, therefore, many of the variables have limited application in neurosurgery. With data collection beginning in 1973, the SEER Program is a longitudinal cancer-specific database that contains information on patient demographics, primary tumor site, tumor morphology and stage at diagnosis, first course of treatment, and follow-up for survival. It contains a 28% sample of cancer diagnoses, and like NIS/KID, it can be used to generate nationwide rates. Outcome is limited to survival and there is no central review to confirm pathology or neuroimaging, both of which have seen such dramatic changes since the birth of SEER that it is difficult to compare information from even 10 years ago.
The neurosurgical subspecialties with the greatest number of articles were vascular (n = 77), neuro-oncology (n = 66), and general (n = 61). The most common primary study objectives were Outcomes (n = 154) and Cost (n = 65). It was also noted that "big data" research using administrative databases or other non-neurosurgery-specific medical record repositories is heavily concentrated among several academic institutions.
Whether by primary or senior author, nearly 50% of all articles that were published in one of 3 North American neurosurgical journals came from about 10 institutions. Prominent academic institutions from both the east and west coast of the US filled the top 5 lists for both primary and senior authors. Harvard Medical School, with its numerous affiliated hospitals, was by far the most productive institute, with nearly double the papers of the next institution, both by primary and senior author.
Advantages and Disadvantages of "Big Data" Use in Neurosurgical Research
Utilizing national or statewide databases for neurosurgical research has a number of advantages. With the data already organized, digitized, and "on the shelf, " a researcher's access to such data and time for analysis is more streamlined than ever at low cost. Databases that are based on real-world clinical practices are able to paint a broad portrait of a particular disease in areas such as demographics, treatments, complications, outcomes, and cost. Geographic and socioeconomic variation in disease prevalence, incidence, treatment, and health care utilization can also be assessed. Institutional review board approval is usually not required because datasets are deidentified and HIPAA (Health Insurance Portability and Accountability Act) compliant. Perhaps the greatest strength of these data sets is a sample size typically much larger than any one institution or even group of institutions could obtain within a reasonable time period. This is especially advantageous when considering uncommon and rare conditions. Large study populations on the scale afforded by these databases allow the researcher to have more precise results and a greater ability to detect small differences within the study population. Large datasets also lend themselves to statistical manipulations and analyses that cannot be performed with small numbers of patients.
Conducting research using ready-made databases that were never designed by neurosurgeons for the study of neurosurgical diseases and-in the case of administrative databases-nor were even intended for research purposes has a number of significant drawbacks. 29, 30 Within neurosurgery, warnings have been issued through a number of editorials and letters to the editor. [31] [32] [33] [34] [35] [36] [37] Kestle 31 identified a number of major limitations, such as the data source, coding issues, linkages, confounders, definitions, and data validation.
One of the most serious weaknesses is data integrity. Inputting the correct information for any patient with any disease and comorbidities requires a substantial amount of medical knowledge. As outlined by van Walraven and Austin, 29 for disease X to be captured accurately in a data set, the following steps must be carried out: (1) the physician must recognize, diagnose, and document "disease X" in the medical chart; and (2) the data abstractor must recognize, correctly interpret, and use the proper code(s) for disease X. The more complex the patient or the process of gathering and importing the information, the greater the risk of introducing errors. Furthermore, these data abstractors work in an isolated, nonclinical setting with no direct patient care and may or may not have educational certification.
Many studies have investigated the reliability of administrative data compared with departmental data. Investigators at the University of Calgary compared chart documentation and administrative data for patients who underwent carotid endarterectomy. 38 They reviewed 2061 charts and found that only 43% were well documented, and furthermore, poorly documented hospital charts directly translated into invalid administrative data. Woodworth et al 39 authored one of very few papers within the neurosurgical literature that evaluated the accuracy of an administrative database against a departmental database. Looking at patients with a treated intracranial cerebral aneurysm, they found that the administrative database (Maryland Health Service Cost Review Commission) missed 16% of all treated patients, was significantly inaccurate in 10 of 12 testing categories, and had positive predictive values (PPV) as low as 30% and as high as 88% in other categories. Another group of investigators compared readmission rates from the University HealthSystem Consortium (UHC, recently renamed Vizient) with their prospectively maintained department database in order to determine, if all coded readmissions should be considered a clinically relevant readmission for the purposes of quality reporting. 40 Based on their review, they recommended exclusion of 25% of the UHC-designated readmissions cases due to clinical irrelevance (ie, rescheduled or staged procedures; unrelated to the index procedure).
Golinvaux et al 41 and Lawson et al 42 both undertook comparisons of 2 big databases (NIS vs NSQIP and CMS claims vs NSQIP, respectively) and found markedly different rates of coded events and low PPV between the 2 data sets. Consequently, in a more recent publication, Lawson et al 43 found that classification of hospital outlier status as better or worse performance than expected for postoperative complications differed substantially between ACS NSQIP and Medicare claims. Other reported database inaccuracies for neurosurgical diseases or procedures are tethered cord release surgery coding, 36 indications for lumbar fusion, 44 complications in lumbar discectomies, 45 classification of spinal column and spinal cord injury, 46 and coding of the presence and degree of obesity in spine surgery patients. 41 Much work is needed on the validation of health administrative data for patients with neurosurgical diseases and conditions. As mentioned in the paper by Lawson et al, 42 there are some pieces of information that administrative data capture very accurately, such as a patient death. Benchimol et al 47 recently proposed a reporting checklist for studies validating administrative data identification algorithms and used this 40-item checklist to assess the quality of reporting of validation studies in the literature. It is clear that threats to data integrity can come from many sources, which directly impact internal and external validity of the research. So, while big databases may be able to provide precise results, such results may be inaccurate, yielding quick but dirty research. 48 While studies that utilize "big data" can technically be considered retrospective cohort in design, it is somewhat a misnomer on the part of "big data" authors to state that they "performed a cohort study." At the core of "big data" research is exploratory data analysis, the results of which should lead to more focused, hypothesis driven studies. Key steps of traditional clinical study design include the formulation of a hypothesis or question, the delineation of inclusion and exclusion criteria, followed by collection and analysis of data. The determination of which data points to collect, the actual data gathering, and concomitant quality control (ie, data integrity) is extremely important (and often the most time consuming aspect of a study). It is interesting to note that only 3 of the publications we reviewed included comparative data from either the primary or senior author's own institution, including the studies by Woodworth et al 39 and Amin et al 40 described above, as well as one other publication that compared institutional data with data from the NIS in order to validate a novel subarachnoid scoring system. 49 In other words, virtually none of the investigators that used a ready-made database attempted to answer the same question(s) or confirm or refute their exploratory data analysis findings with data from their own institution(s).
With big database research, any hypothesis and testing of said hypothesis is limited by what data are available and-as discussed previously-data integrity. Even quality-focused databases, such as ACS NSQIP (which in our opinion are superior to administrative databases in some respects), were not designed for neurosurgical diseases and thus many of the variables and outcomes that are available for analysis have little-to-no value and lack variables that are of value to neurosurgeons. 34 Because of the lack of neurosurgical variables, neurosurgical researchers are forced to ask questions that have debatable relevance or interest to other neurosurgeons. Furthermore, outcomes in NSQIP are limited to only 30-days postprocedure. 50 NSQIP has recently added specialtyspecific variables to capture data on procedures identified as most interesting, such as spine surgery and shunts, but there are no resulting publications to date. However, there are potential opportunities to improve and supplement administrative data by linking it with other data sources, such as electronic health records or existing registries, as well as enhancements in coding (International Classification of Disease, 9th edition [ICD-9] vs ICD-10). 30, 51, 52 In general, measures captured in national or state databases may be better suited to answer more superficial, broad, or generic questions regarding quality, cost, complications, or outcomes, but are unable to take into account the granular nuances of a specialty service, such as neurosurgery, that are most relevant to providers and consumers.
Publications that utilize big databases are generally lauded and accepted as authoritative and accurate. They are favored by journals, likely stemming from their large patient populations and complex statistics with numerous P-values. 39 The Results section of many big data articles contains univariate followed by multivariate analyses on the outcome(s) of interest, the consequence often being an inordinate number of P-values. Authors then proceed to expound on all "statistically significant" findings (those with an arbitrarily designated P-value of <.05) with little discussion on the magnitude of the effect size or clinical meaningfulness. Large sample sizes can generate statistically significant findings, but with very small effect size and no clinical meaning. Further, as samples become large, there is greater likelihood that "noise" in the data or other chance variations can give the appearance of an effect that could be statistically significant, as Cohen states. 53 Misconceptions and misuse of P-values within medical literature is well recognized. [53] [54] [55] This has led some to use the quote "garbage in, gospel out," first coined in the field of computing science as a warning to avoid blindly believing the outcome when the input is of questionable integrity. 56 Important information, such as vital signs, commonly used neurosurgical scales (eg, Glasgow Coma Scale, Glasgow Outcome Scale, Hunt and Hess, modified Rankin, etc.), laboratory or diagnostic test results, operative notes, functional status, and postoperative issues or complications that occur after discharge are often not recorded in administrative databases. Finally, administrative databases were originally created for billing purposes, so the codes recorded by data abstracters are often driven by reimbursement policies rather than any attendant interest in research, a clear source of bias. 30 As stated by van Walraven, "Data sets are significantly more complete when those responsible for supplying its information benefit in some way from providing those data."
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Strengths and Limitations
To our knowledge, this is the first publication that examines the ascension of "big data" research in the neurosurgical literature. We limited our analysis only to the 3 main US neurosurgical journals, which underestimates the true overall presence of such studies within the global neurosurgical literature. We may have missed some articles within these 3 journals using our search strategies, but we feel confident that most articles were identified. Given the large number of articles, we could not delve into the minutia or statistical validity of each article. However, we do plan a more detailed analysis of a subset of big database articles where we will critically evaluate the strength of associations (P-value), the precision of the estimates (confidence interval), and the magnitude of the observed differences (effect sizes). One could argue that we were too simplistic in our categorization of articles based on their broad and specific topics, as well as their objective. Finally, one important question that cannot be answered objectively by our analysis is what-if any-impact "big data" research has or will have on neurosurgery as a whole or on individual or group practices.
CONCLUSION
Publications in the neurosurgical literature using nonneurosurgery-specific, ready-made databases have dramatically increased over the last 6 years. The value of such studies remains to be determined. Such reports have distinct advantages over traditional single or multicenter retrospective clinical research and will continue to play an important role in neurosurgical health services research. Despite their large study populations and associated statistical analysis, not enough emphasis has been placed on the many limitations that come with using these data repositories. We urgently recommend journal editors to establish criteria that determine what clinical questions are appropriate for such databases and which are not, and establishing benchmarks for methodologic quality, transparency, data integrity, as well as reporting for these types of publications.
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